TF and cancer: Another ligand EFNA1 (cell–cell signaling) is received by receptor EPHA1 to trigger TF PDX1, which is modified by phosphorylation to cause activation [27], and to upregulate target gene MIRLET7C. Gene MIRLET7C is a tumor suppressor gene, suppressing cancer cell proliferation in normal cells [28].